LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で29.00%の成長率を示しています。
高い利益成長
同社の純利益は業界をリードしており、最新の年間純利益はUSD 249.60Mです。
高配当
同社は高配当銘柄であり、最新の配当性向は32.65%です。
安定配当
同社は過去5年間にわたり継続的に配当を実施しており、最新の配当性向は32.65%です。
割安
同社の最新のPEは36.84で、過去3年間の水準と比較して安値圏にあります。
機関投資家の買い増し
最新の機関投資家の保有株数は23.53M株で、前四半期比で3.50%増加しています。
HACAXが保有
スター投資家HACAXは本銘柄を10.24K株保有しています。